CaMKII activation and regulation in adult cardiac myocytes
CaMKII activation and regulation in adult cardiac myocytes
批准号:
10687251
负责人:
Donald M Bers
金额:
$72.12万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
未结题
起止时间:
2018-04-18 至 2026-06-30
关键词:
AcuteAdultAffectAffinityAmericanAnimalsArrhythmiaBindingBinding SitesBiochemistryCa(2+)-Calmodulin Dependent Protein KinaseCalcineurinCalciumCardiacCardiac MyocytesCardiovascular DiseasesCellsChronicComplexCyclic AMPCyclic AMP-Dependent Protein KinasesDataDefectDevelopmentDiabetes MellitusEFRACFailureFatty acid glycerol estersFluorescence Resonance Energy TransferFunctional disorderGelGene ExpressionGeneticGenetic TranscriptionHeartHeart failureHistone DeacetylaseHomeostasisHyperglycemiaImageIndividualIon ChannelIonsKnock-in MouseKnowledgeLinkMeasuresMediatingMemoryMetabolismMethylationMicrofilamentsModelingMolecularMolecular ConformationMuscle CellsMutationNG-Nitroarginine Methyl EsterNeuronsNitric Oxide SynthaseNuclearPathologicPathologyPatientsPhenotypePhosphorylationPhosphotransferasesPlayPost-Translational Protein ProcessingProcessProductionProteinsRegulationReporterResistanceRoleSiteSystemTestingTherapeuticTherapeutic InterventionTissuesTransducerscalmodulin-dependent protein kinase IIdiabeticfallsheart functionindium arsenideinnovationmutantnoveloxidationpreservationpressurepreventresponsesynergismtargeted treatment
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/ Abstract
Ca-Calmodulin dependent protein kinase (CaMKII) is an important regulator of cardiac function,
and dysfunction in pathological states, regulating ion channels, Ca transporters, myofilaments
and nuclear transcription. CaMKII may normally fine-tune these processes. But in pathological
conditions like heart failure (HF), chronic autonomous CaMKII activation can over-phosphorylate
targets, contributing to arrhythmogenesis due to acute effects on several ion channels and Ca-
handling proteins. Chronic CaMKII activation is also a hallmark of several pathological states
and acute or genetic CaMKII inhibition can reduce arrhythmias and the progression of HF. Thus
understanding fundamental aspects of CaMKII regulation in cardiac myocytes is critical
understanding dysfunction and potential therapeutics. We and others discovered several novel
post-translational modifications (PTMs) that can trap CaMKII in an activated state, rather than
turning on & off rapidly with local Ca transients. Autophosphorylation, oxidation, GlcNAcylation
and S-nitrosylation within a regulatory hotspot on CaMKII creates memory and autonomous
activity, even when Ca/CaM falls. There are also 3 PTMs at other sites that suppress CaMKII
activation. Aims 1 and 2 will directly measure how these PTMs differentially affect activation and
memory of CaMKII in adult cardiac myocytes, to fill a major knowledge gap in this field. Aim 3
will test whether CaMKII S-nitrosylation at a single site is required for the heart’s intrinsic
response to increase Ca transients and contraction in response to acute and chronic pressure
overload (or the Anrep effect). CaMKII has well-recognized roles in HF with reduced ejection
(HFrEF), but its role in HF with preserved ejection (HFpEF) is unclear. Aim 4 will directly test the
engagement of CaMKII in two new HFpEF models. The proposed studies will have major impact
on our understanding of how CaMKII activity is regulated in heart, in ways that promote
pathology and might be targets for therapeutic intervention.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Neuron-Restrictive Silencer Factor Limits Myocyte GαO Expression and Is Protective in Heart Failure Progression.
神经元限制性沉默因子限制肌细胞 GαO 表达并在心力衰竭进展中具有保护作用。
DOI:
10.1161/circresaha.121.320597
发表时间:
2022
期刊:
Circulation research
影响因子:
20.1
作者:
[Sossalla,Samuel, Bers,DonaldM]
通讯作者:
Bers,DonaldM
DOI:
10.1016/j.yjmcc.2018.10.010
发表时间:
2018-12
期刊:
Journal of molecular and cellular cardiology
影响因子:
5
作者:
[Wood BM, Simon M, Galice S, Alim CC, Ferrero M, Pinna NN, Bers DM, Bossuyt J]
通讯作者:
Bossuyt J
CaMKII and PKA-dependent phosphorylation co-regulate nuclear localization of HDAC4 in adult cardiomyocytes.
CaMKII 和 PKA 依赖性磷酸化共同调节成体心肌细胞中 HDAC4 的核定位。
DOI:
10.1007/s00395-021-00850-2
发表时间:
2021-02-15
期刊:
Basic research in cardiology
影响因子:
9.5
作者:
[Helmstadter KG, Ljubojevic-Holzer S, Wood BM, Taheri KD, Sedej S, Erickson JR, Bossuyt J, Bers DM]
通讯作者:
Bers DM
DOI:
10.1126/sciadv.abg0927
发表时间:
2021-11-19
期刊:
Science advances
影响因子:
13.6
作者:
[Morotti S, Liu C, Hegyi B, Ni H, Fogli Iseppe A, Wang L, Pritoni M, Ripplinger CM, Bers DM, Edwards AG, Grandi E]
通讯作者:
Grandi E
DOI:
10.1073/pnas.2108484118
发表时间:
2021-08-03
期刊:
Proceedings of the National Academy of Sciences of the United States of America
影响因子:
11.1
作者:
[Hegyi B, Shimkunas R, Jian Z, Izu LT, Bers DM, Chen-Izu Y]
通讯作者:
Chen-Izu Y
共 6 条
Training Program in Pharmacology
-
批准号:10656570
-
项目类别:
-
资助金额:$41.43万
-
财政年份:2022
-
负责人:Donald M Bers
-
依托单位:
Systems Approach to Understanding Cardiovascular Disease and Arrhythmias - Cell diversity in the cardiovascular system, cell-autonomous and cell-cell signaling
-
批准号:10386681
-
项目类别:
-
资助金额:$3.0万
-
财政年份:2021
-
负责人:Donald M Bers
-
依托单位:
Project 2 (Bers)
-
批准号:10677715
-
项目类别:
-
资助金额:$74.77万
-
财政年份:2019
-
负责人:Donald M Bers
-
依托单位:
Systems Approach to Understanding Cardiac Arrhythmias Mechanisms
-
批准号:9763307
-
项目类别:
-
资助金额:$3.0万
-
财政年份:2019
-
负责人:Donald M Bers
-
依托单位:
Project 2 (Bers)
-
批准号:10006341
-
项目类别:
-
资助金额:$74.77万
-
财政年份:2019
-
负责人:Donald M Bers
-
依托单位:
Modelling structural and functional heterogeneity in heart failure reveals arrhythmic impact
-
批准号:10199780
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2019
-
负责人:Donald M Bers
-
依托单位:
Modelling structural and functional heterogeneity in heart failure reveals arrhythmic impact
-
批准号:10449125
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2019
-
负责人:Donald M Bers
-
依托单位:
Project 2 (Bers)
-
批准号:10249148
-
项目类别:
-
资助金额:$74.77万
-
财政年份:2019
-
负责人:Donald M Bers
-
依托单位:
Project 2 (Bers)
-
批准号:10471339
-
项目类别:
-
资助金额:$74.77万
-
财政年份:2019
-
负责人:Donald M Bers
-
依托单位:
High-Throughput Screens to Discover Novel Inhibitors of Leaky RyR2 for Heart Failure Therapy
-
批准号:10064096
-
项目类别:
-
资助金额:$75.42万
-
财政年份:2018
-
负责人:Donald M Bers
-
依托单位:
CaMKII activation and regulation in adult cardiac myocytes
-
批准号:10540169
-
项目类别:
-
资助金额:$71.29万
-
财政年份:2018
-
负责人:Donald M Bers
-
依托单位:
CaMKII activation and regulation in adult cardiac myocytes
-
批准号:9905549
-
项目类别:
-
资助金额:$62.77万
-
财政年份:2018
-
负责人:Donald M Bers
-
依托单位:
AKAP-dependent regulation of Cardiac SR Ca handling
-
批准号:9910438
-
项目类别:
-
资助金额:$49.6万
-
财政年份:2017
-
负责人:Donald M Bers
-
依托单位:
Molecular examination of mitochondrial calcium control
-
批准号:9315886
-
项目类别:
-
资助金额:$77.04万
-
财政年份:2016
-
负责人:Donald M Bers
-
依托单位:
Molecular examination of mitochondrial calcium control
-
批准号:10521276
-
项目类别:
-
资助金额:$69.12万
-
财政年份:2016
-
负责人:Donald M Bers
-
依托单位:
Molecular examination of mitochondrial calcium control
-
批准号:9462645
-
项目类别:
-
资助金额:$75.82万
-
财政年份:2016
-
负责人:Donald M Bers
-
依托单位:
Molecular examination of mitochondrial calcium control
-
批准号:10320799
-
项目类别:
-
资助金额:$69.86万
-
财政年份:2016
-
负责人:Donald M Bers
-
依托单位:
Multi-scale Systems Model of Murine Heart Failure
-
批准号:8211851
-
项目类别:
-
资助金额:$73.71万
-
财政年份:2012
-
负责人:Donald M Bers
-
依托单位:
Pharmacology Training: Bench to Bedside
-
批准号:8875706
-
项目类别:
-
资助金额:$22.21万
-
财政年份:2012
-
负责人:Donald M Bers
-
依托单位:
Pharmacology Training: Bench to Bedside
-
批准号:8214224
-
项目类别:
-
资助金额:$7.21万
-
财政年份:2012
-
负责人:Donald M Bers
-
依托单位:
海外基金